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Helicobacter Pylori gastritis and risk of ischaemic stroke
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Abstract
Objective: To identify the association between H. Pylori gastritis and stroke. 
Method: Patients with biopsy proven H.Pylori gastritis and non H.Pylori gastritis were enrolled. Patients were
followed for a period of two years. 
Results: A total of 326 patients were included in the study. 162 patients were with H.Pylori gastritis. There was no
significance difference in age, sex and duration of symptoms in the two groups. Three patients in H.Pylori group
had stroke or TIA as compared to one in non H.Pylori group. Patients with H Pylori gastritis were more likely to die
or have cardiac and or neurological event as compared to Non H pylori gastritis (OR 1.23, 95% CI 0.89-1.67). This
relationship was not significant after adjusting for cardiovascular risk factors (AOR 0.85, 95% CI 0.45- 1.31). 
Conclusion: H. Pylori gastritis is not independently associated with increased risk for stroke. Larger, randomized
studies are needed to confirm our findings (JPMA 58:368;2008).
Introduction
An association between chronic infections and
atherosclerosis has been a topic of great interest for
researcher for the last decade.1 The association between
Helicobacter Pylori infection and atherosclerosis and
coronary artery disease has long been debated.2
An association between Helicobacter Pylori infection
and stroke has been recently suggested.3-5 Recent studies
suggested that H Pylori infection is more likely to be related
to large vessel or small vessel stroke as compared to
cardioembolic stroke. Masoud et al from Iran reported an
association between H Pylori infection and non
cardioembolic ischemic stroke.6 Investigators from Korea
identified that H Pylori seropositivity was significantly more
common in Large artery stroke patients as compared to
control group (87% vs 60%, P<0.001).7 H Pylori
seropositivity was associated with all stroke subtypes (OR
1.63, 95%CI: 1.02-2.60), lacunar or small artery strokes (OR
2.21, 95%CI: 1.12-4.38) and large vessel stroke (OR 2.58,
95%CI: 1.44-4.63) in another study.8 Heuschmann showed
that chronic H Pylori infection was associated with higher
risk of small artery stroke (OR 3.31, CI 1.15-9.56). It was not
a significant factor for all stroke subtypes.9 Pietroiusti et al
reported high likelihood of large vessel stroke as compared
to cardioembolic stroke (OR 3.04, CI 1.43-6.49) and as
compared to control subjects (OR 4.3, CI 2.12-8.64).10
More recent data suggested that a specific strain of H
Pylori (CAG-A positive strain) was more strongly associated
with risk of stroke as compared to other strains.11-13 All these
studies have looked for antibodies against H Pylori among
stroke patients and compared them with control population.
Our study is the first study to follow patients with proven H
Pylori gastritis over a period of time to identify risk of stroke
in comparison to a control population.
Patients and Methods
Patients with biopsy proven H Pylori gastritis and
non- H pylori gastritis (control group) were enrolled in the
study at The Aga Khan University, Karachi during 1999-
2000. All patients were evaluated for cardiac or stroke risk
factors including Hypertension, Diabetes and Smoking.
Patients were followed for a mean of two years by telephone
or office visits. Stroke or TIA was defined as primary end
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point. Angina or Myocardial infarction was defined as
secondary endpoint. These patients were divided in two
groups based on visualization of Helicobacter Pylori on
H&E and or Giemsa stain. Patients with no H Pylori on
gastric biopsy were labeled as non- H Pylori gastritis.
All patients with H Pylori gastritis were treated with
standard treatment and patients with non H Pylori gastritis
were treated with proton pump inhibitors, H2 receptor
antagonists and Antacid preparations. Patients with
Hypertension and Diabetes were treated with standard anti
Hypertensive and ant Diabetic medications. Diagnosis of
stroke or TIA was confirmed by a neurologist based on
neurological history and exam and MRI findings and
diagnosis of Angina or Myocardial infarction was established
by a cardiologist based on EKG findings and cardiac enzymes. 
We performed chi square tests for significance
between two groups (H Pylori gastritis and non H Pylori
gastritis). Association between death or neurological event
(stroke or TIA) or cardiac event (Angina or MI) and H Pylori
gastritis was analyzed by Logistic regression analysis.
Adjusted analysis was done after adjusting for stroke or
cardiac risk factors (Hypertension, Diabetes and Smoking).
Results
Four hundred thirty four patients with sub acute to
chronic gastritis were enrolled (H Pylori group= 210, Non
H Pylori group= 224), of these 108 (25%) were lost for
follow up and 326 patients were included in the study (H
Pylori group= 162 patients, Non H Pylori group= 164).
Risk factors profile of two groups was not
significantly different except Hypertension was more
prevalent in H Pylori group (Table). Three patients in H
Pylori group had stroke during two years follow up
(stroke=2, TIA=1) as compared to one in non H Pylori
group. All four patients had positive risk factors for stroke.
Three patients died in H Pylori group as compared to one in
non H Pylori group. The cause of death was cardiac= 2
patients, gastrointestinal bleeding=1 patient and
unknown=1 patient. Patients with H Pylori gastritis were
more likely to die or have cardiac and or neurological event
as compared to Non H pylori gastritis (OR 1.23, 95% CI
0.89-1.67). This relationship was not significant after
adjusting for cardiovascular risk factors (AOR 0.85, 95% CI
0.45- 1.31). 
Discussion
Our study failed to show an independent association
between H pylori gastritis and stroke. Combined risk of
cardiac or neurological event and death was increased
among patients with H Pylori gastritis but this was not
significant after adjusting for cardiovascular risk factors. 
There are many limitations to our study. About 25%
patients were lost to follow up. Major reason for loss to
follow up was non availability of telephone. Incidence of
stroke among patients or controls was extremely low and
non significant. Atherosclerosis and associated coronary or
cerebrovascular disease is probably associated with
prolonged, untreated H Pylori infection. Most of the
published studies have looked at the IgG antibodies against
H Pylori as evidence of infection. These antibodies remain
positive even after eradication of the organism from gastric
mucosa and complete relief of symptoms. Previous studies
have not mentioned if those patients with positive IgG
against H Pylori had symptoms of H Pylori gastritis or their
status of treatment or eradication. It is likely that only
patients with chronic, untreated H Pylori infections develop
atherosclerotic complications like stroke. It is possible that
this treatment may have decreased their risk of stroke up to
the level of control population in our study.
Another limitation of our study is the period of
follow up. There is no data to suggest time lag between H
Pylori infection and development of atherosclerosis. It is
possible that two years time is not enough for development
of stroke and these patients may need a longer follow up.
A much larger sample size would be required to
detect a statistically significant difference when comparing
this group to patients with non H Pylori gastritis. An ideal
Table. Comparison of baseline characteristics and follow up data.
H Pylori
(n=162)
Non H pylori 
(n= 164)
P value
Baseline:
Age:
Range
Mean (SD)
Male
Females
Duration of symptoms (Mean)
Hypertension
Diabetes
Cigarette smoking
Previous stroke
Follow up:
Duration:
Range
Mean
Death or cardiac or
eurological event, any
Stroke
Transient ischaemic attack
Myocardial infarction
Angina
Death
No cardiac/ neurological events
18-69
46 (SD??)
90 (56%)
72 (44%)
5 weeks
33 (20%)
15 (9%)
26 (16%)
1
20-38
28 months
12 (7%)
2
1
0
6
3
149 (92%)
20-68
46 (SD??)
82 (50%)
82 (50%)
7 weeks
17 (10%)
9 (5%)
17 (10%)
0
24-37 months
29 months
4 (2%)
1
0
1
1
1
159 (97%)
0.15
NS
0.05
0.09
0.088
NS
NS
0.05
NS
NS
NS
NS
NS
0.059
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cohort to follow according to this study design would be the
patients with H.Pylori in appropriate age group and
followed for 10 - 15 years may give us the answer.   
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Carotid Artery Stenting in High Risk Patients - results of first twelve patients at
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Abstract
Objective: Carotid artery stenting (CAS) is emerging as an alternative procedure to carotid endarterectomy. It is
mostly performed in patients with high surgical risk.  Many centers in Pakistan have started CAS.  We present
results of 1st twelve patients who underwent carotid artery stenting at Shifa International Hospital, Islamabad.  
Methods: Our carotid intervention team is comprised of a vascular neurologist, interventional cardiologist and
interventional radiologist. Based on high risk criteria/patient choice, patients are recruited for CAS. Carotid artery
stenting using standard technique with embolic protection device is performed. 
Results: Twelve carotid artery stenting procedures were done between August 2006 and March 2008.  One
patient had TIA before stent deployment and was excluded from final analysis.  Of the other 11 patients, ten were
males, with mean age of 68.2 ± 11.3 years (median age 71). Ten were symptomatic; one asymptomatic with
complete occlusion of contralateral internal carotid artery.  High-risk criteria were present in all: complete
contralateral occlusion (2 patients); age greater than 70 years (7 patients); severe coronary artery disease (7
patients) and previous ipsilateral endarterectomy (1 patient).  The stenosis ranged between 60-95%. Embolic
protection device was used in nine (82%).  Five (46%) patients developed hypotension requiring intravenous
vasopressors.  One of them developed persistent hypotension despite maximum pressor support and died.
None developed neurological deterioration, acute renal failure, or haematomas/ pseudoaneurysm formation.
One-year follow-up is available on two patients with patent stent and no neurological events.
Conclusion: Hypotension is a common and potentially lethal complication of carotid artery stenting.  Our results
suggest that a multidisciplinary team approach with availability of specialized care can provide results
comparable to internationally acceptable outcomes (JPMA 58:370;2008).
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